NM_000754.4:c.*522G>C

Variant summary

Our verdict is Uncertain significance.
+2 Uncertain · Warm
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 2 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_Moderate

The NM_000754.4(COMT):c.*522G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The gene COMT is a tumor suppressor gene (CancerMine: 3 TSG citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 33)

Consequence

COMT
NM_000754.4 3_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0760

Publications

233 publications found
Variant links:
Genes affected
COMT (HGNC:2228): (catechol-O-methyltransferase) Catechol-O-methyltransferase catalyzes the transfer of a methyl group from S-adenosylmethionine to catecholamines, including the neurotransmitters dopamine, epinephrine, and norepinephrine. This O-methylation results in one of the major degradative pathways of the catecholamine transmitters. In addition to its role in the metabolism of endogenous substances, COMT is important in the metabolism of catechol drugs used in the treatment of hypertension, asthma, and Parkinson disease. COMT is found in two forms in tissues, a soluble form (S-COMT) and a membrane-bound form (MB-COMT). The differences between S-COMT and MB-COMT reside within the N-termini. Several transcript variants are formed through the use of alternative translation initiation sites and promoters. [provided by RefSeq, Sep 2008]
COMT Gene-Disease associations (from GenCC):
  • paroxysmal dyskinesia
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
ARVCF (HGNC:728): (ARVCF delta catenin family member) Armadillo Repeat gene deleted in Velo-Cardio-Facial syndrome (ARVCF) is a member of the catenin family. This family plays an important role in the formation of adherens junction complexes, which are thought to facilitate communication between the inside and outside environments of a cell. The ARVCF gene was isolated in the search for the genetic defect responsible for the autosomal dominant Velo-Cardio-Facial syndrome (VCFS), a relatively common human disorder with phenotypic features including cleft palate, conotruncal heart defects and facial dysmorphology. The ARVCF gene encodes a protein containing two motifs, a coiled coil domain in the N-terminus and a 10 armadillo repeat sequence in the midregion. Since these sequences can facilitate protein-protein interactions ARVCF is thought to function in a protein complex. In addition, ARVCF contains a predicted nuclear-targeting sequence suggesting that it may have a function as a nuclear protein. [provided by RefSeq, Jun 2010]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000754.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 2 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2])

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000754.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

COMT NM_000754.4
MANE Select
HGVSc / HGVSpc.*522G>C
Exon rankExon 6 of 6
3_prime_UTR
Prot: NP_000745.1UniProt: P21964-1A0A140VJG8
COMT NM_001135161.2
HGVSc / HGVSpc.*522G>C
Exon rankExon 6 of 6
3_prime_UTR
Prot: NP_001128633.1UniProt: P21964-1A0A140VJG8
COMT NM_001135162.2
HGVSc / HGVSpc.*522G>C
Exon rankExon 6 of 6
3_prime_UTR
Prot: NP_001128634.1UniProt: P21964-1A0A140VJG8

Ensembl Transcripts

COMT ENST00000361682.11
TSL:1MANE Select
HGVSc / HGVSpc.*522G>C
Exon rankExon 6 of 6
3_prime_UTR
Prot: ENSP00000354511.6UniProt: P21964-1
COMT ENST00000678769.1
HGVSc / HGVSpc.*522G>C
Exon rankExon 7 of 7
3_prime_UTR
Prot: ENSP00000503289.1UniProt: A0A7I2V370
COMT ENST00000852828.1
HGVSc / HGVSpc.*522G>C
Exon rankExon 7 of 7
3_prime_UTR
Prot: ENSP00000522887.1UniProt: A0ACI8VGL7

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:33
GnomAD4 exome
Cov:0
GnomAD4 genome
Cov:33
Showing 3 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign2.1
BayesDel_noAF
Benign-0.87
CADD
Benign1.4
DANN
Benign0.42
GPN-Star LLR
N/A-0.59
GPN-Star score
N/A0.59
PhyloP100
Benign0.076
Showing 7 of 7 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.